Developing malaria vaccines: Investing in the tools of the trade
Read more »
Photo credit: Paul Quinlan
Partnering with us
We are pursuing a range of vaccine development approaches with an expanding circle of industry, academic, and government partners.
Our portfolio
We maintain a diverse portfolio of projects, including preclinical feasibility studies, translational projects, and one advanced clinical project.
What we do and how we do it
We provide funding and technical support to partners worldwide to accelerate the development of malaria vaccines. We also work to ensure that malaria vaccines will reach those who need them.
MVI collaborates with International AIDS Vaccine Initiative and Imperial College London
New central "reference" lab to standardize ability to measure performance of malaria vaccine formulations.
MVI names eminent malaria scientists and vaccinologists to advisory council
MVI welcomes new members to its Vaccine Science Portfolio Advisory Council.
MVI collaborates with National Institute of Allergy and Infectious Diseases and Johns Hopkins
Partnership to evaluate potential vaccine candidate designed to prevent malaria transmission from mosquitoes to humans.
Twitter
Flickr